---
$id: https://graph.org.ai/products/commodity/51152023
$type: Product
source: UNSPSC
code: "51152023"
title: "Dantrolene"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dantrolene

**UNSPSC Code**: 51152023
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscle relaxant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F64QU97QCR. European Medicines Agency schedules Dantrolene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06903MIG. Dantrolene generally arises in the molecular formula C14H10N4O5. The term DANTROLENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 no. 12 1967, list 7.) DANTROLENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dantrolene under HS 29349990 and SITC 51579. As of Q4 2014, DANTROLENE remains the US FDA Preferred Term for this commodity. Dantrolene bears US NLM identifiers UMLS ID C0010976 and NCI Concept Code C61697. SMILES: O1C(C2CCC([N](=O)O)CC2)CCC1/C=N/N1CC(=O)NC1=O.

